Attached files
| file | filename |
|---|---|
| EX-99.4 - EXHIBIT 99.4 - Ocuphire Pharma, Inc. | brhc10018438_ex99-4.htm |
| EX-99.3 - EXHIBIT 99.3 - Ocuphire Pharma, Inc. | brhc10018438_ex99-3.htm |
| 8-K/A - 8-K/A - Ocuphire Pharma, Inc. | brhc10018438_8ka.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statement Form S-4 of Rexahn Pharmaceuticals, Inc. of our report dated July 1, 2020,
with respect to the financial statements of Ocuphire Pharma, Inc. included in this Current Report on Form 8-K/A.
/s/ Ernst & Young LLP
Detroit, Michigan
December 30, 2020